People with more of a specific fat found in dairy products like butter and cheese in their blood have a lower chance of getting type 2 diabetes, even after accounting for how much dairy they eat.
Scientific Claim
Higher plasma concentrations of vaccenic acid (18:1n-7t), a ruminant-derived trans fatty acid, are associated with a 28% lower risk of developing type 2 diabetes per standard deviation increase, independent of dairy intake and other fatty acids, suggesting its biological role may differ from industrial trans fats.
Original Statement
“Some rTFA subtypes were inversely associated with diabetes risk: vaccenic acid (18:1n-7t; hazard ratio [HR] per SD 0.72; 95% CI 0.58–0.89)... The inverse association of 18:1n-7t with diabetes risk was largely unaffected.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational and reports hazard ratios with confidence intervals, so 'associated with' is the correct verb strength. The authors appropriately avoided causal language and adjusted for multiple confounders.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether the inverse association between plasma vaccenic acid and type 2 diabetes is consistent across diverse populations and study designs, and whether it remains significant after harmonizing measurement methods.
Whether the inverse association between plasma vaccenic acid and type 2 diabetes is consistent across diverse populations and study designs, and whether it remains significant after harmonizing measurement methods.
What This Would Prove
Whether the inverse association between plasma vaccenic acid and type 2 diabetes is consistent across diverse populations and study designs, and whether it remains significant after harmonizing measurement methods.
Ideal Study Design
A meta-analysis of 15+ prospective cohort studies with individual participant data, using standardized gas chromatography–mass spectrometry to measure plasma vaccenic acid at baseline, adjusting for identical covariates (BMI, diet, activity, etc.), and reporting incident type 2 diabetes confirmed by medical records over ≥5 years of follow-up.
Limitation: Cannot prove causation or rule out residual confounding from unmeasured dietary or lifestyle factors.
Randomized Controlled TrialLevel 1bWhether increasing plasma vaccenic acid levels through dietary supplementation directly reduces insulin resistance or delays type 2 diabetes onset.
Whether increasing plasma vaccenic acid levels through dietary supplementation directly reduces insulin resistance or delays type 2 diabetes onset.
What This Would Prove
Whether increasing plasma vaccenic acid levels through dietary supplementation directly reduces insulin resistance or delays type 2 diabetes onset.
Ideal Study Design
A double-blind, placebo-controlled RCT of 500 adults with prediabetes, randomized to receive 2.5g/day of purified vaccenic acid (from dairy fat) or placebo for 18 months, with primary outcome of HbA1c change and secondary outcomes of fasting insulin and HOMA-IR, measured at baseline, 6, 12, and 18 months.
Limitation: Ethical and practical challenges in isolating a single fatty acid; may not reflect natural dietary exposure.
Prospective Cohort StudyLevel 2bIn EvidenceWhether the association between plasma vaccenic acid and type 2 diabetes is reproducible in a different population with similar measurement precision.
Whether the association between plasma vaccenic acid and type 2 diabetes is reproducible in a different population with similar measurement precision.
What This Would Prove
Whether the association between plasma vaccenic acid and type 2 diabetes is reproducible in a different population with similar measurement precision.
Ideal Study Design
A prospective cohort study of 10,000 middle-aged adults across multiple countries, measuring plasma phospholipid vaccenic acid at baseline via standardized GC-MS, with 10-year follow-up for incident type 2 diabetes confirmed by physician diagnosis and HbA1c testing.
Limitation: Still observational; cannot eliminate confounding by unmeasured factors.
Evidence from Studies
Supporting (1)
Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort
This study found that people with higher levels of a specific fat found in dairy products (vaccenic acid) were less likely to get type 2 diabetes, even when accounting for how much dairy they ate — suggesting this fat might be healthy in a way that artificial trans fats aren't.